|
Age
| |
|
Median
|
57.5 years
|
|
Range
|
41 – 73 years
|
|
Sex
|
|
Male
|
10 (56 %)
|
|
Female
|
8 (44 %)
|
|
0
|
8 (44 %)
|
|
1
|
10 (56 %)
|
|
Pancreatic tumor location
|
|
Head
|
11 (61 %)
|
|
Uncinate process
|
3 (17 %)
|
|
Body
|
2 (11 %)
|
|
Tail
|
2 (11 %)
|
|
Biliary stent
|
|
Yes
|
9 (50 %)
|
|
No
|
9 (50 %)
|
|
Serum bilirubin level prior to chemotherapy
|
|
Median
|
0.35 mg/dl
|
|
Range
|
0.1 – 1.2 mg/dl
|
|
Basis for unresectability
|
|
Borderline resectable
|
|
SMV encased (short segment)
|
3 (17 %)
|
|
SV encased
|
1 (6 %)
|
|
SMV encased (long segment)
|
1 (6 %)
|
|
SMA encased
|
3 (17 %)
|
|
HA encased
|
2 (11 %)
|
|
Celiac trunk encased
|
3 (17 %)
|
|
Confluence of PV, SV and SMV encased
|
5 (28 %)
|
